Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Chemcon Speciality Chemicals's Debt-to-EBITDA or its related term are showing as below:
NSE:CHEMCON'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.07 Med: 0.52 Max: 1.17
Current: 1.17
During the past 9 years, the highest Debt-to-EBITDA Ratio of Chemcon Speciality Chemicals was 1.17. The lowest was 0.07. And the median was 0.52.
NSE:CHEMCON's Debt-to-EBITDA is ranked better than 66.26% of 1242
companies
in the Chemicals industry
Industry Median: 2.15
vs NSE:CHEMCON: 1.17
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Chemcon Speciality Chemicals Debt-to-EBITDA Related Terms
Chemcon Speciality Chemicals Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CHEMCON vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Chemcon Speciality Chemicals's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemcon Speciality Chemicals Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Chemcon Speciality Chemicals's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Chemcon Speciality Chemicals's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Chemcon Speciality Chemicals (NSE:CHEMCON) has a Debt-to-EBITDA of 0.00 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Chemcon Speciality Chemicals. Over the past decade, Chemcon Speciality Chemicals' Debt-to-EBITDA has ranged from 0.07 to 1.17. According to the industry distribution chart, Chemcon Speciality Chemicals ranks #419 out of 1242 companies in the Chemicals industry, placing it in the top 33.7%.
Is Chemcon Speciality Chemicals' Debt-to-EBITDA too high?
Chemcon Speciality Chemicals' current Debt-to-EBITDA is 0.00. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 1.17. Based on the distribution chart, Chemcon Speciality Chemicals ranks #419 out of 1242 companies in the Chemicals industry, which is above the industry midpoint. Overall, Chemcon Speciality Chemicals has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chemcon Speciality Chemicals' Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Chemcon Speciality Chemicals ranks #419 out of 1242 companies for Debt-to-EBITDA. This puts Chemcon Speciality Chemicals in the upper half of its industry. The industry median Debt-to-EBITDA is 2.15. Historically, Chemcon Speciality Chemicals' own Debt-to-EBITDA has ranged from 0.07 to 1.17 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.15, based on 1,242 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Chemcon Speciality Chemicals. For the Chemicals industry, the median Debt-to-EBITDA is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemcon Speciality Chemicals's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemcon Speciality Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Chemcon Speciality Chemicals (NSE:CHEMCON) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹221.26, compared to a current price of ₹189.55 — trading 14.3% below its estimated fair value. The current Debt-to-EBITDA is 0.00. Chemcon Speciality Chemicals' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Chemcon Speciality Chemicals (NSE:CHEMCON), the current Debt-to-EBITDA is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemcon Speciality Chemicals (NSE:CHEMCON) Overvalued in 2026?
Based on GuruFocus' analysis, Chemcon Speciality Chemicals stock appears to be undervalued.
The current stock price of ₹189.55 is trading 14.3% below its estimated GF Value™ of ₹221.26.
GuruFocus considers Chemcon Speciality Chemicals to be Modestly Undervalued.
Key valuation signals for NSE:CHEMCON:
Debt-to-EBITDA: 0.00
GF Value™: ₹221.26 vs. price of ₹189.55 (14.3% below fair value)
No single metric tells the full story. See the NSE:CHEMCON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemcon Speciality Chemicals Ltd manufactures specialized chemicals including Hexamethyldisilazane and Chloromethyl Isopropyl Carbonate, which are mainly used in the pharmaceutical industry. The company also produce inorganic bromides such as Calcium Bromide, Zinc Bromide, and Sodium Bromide, which are used as completion fluids in the oilfields industry. The company's product lines include Oilfield Chemicals, Pharmaceutical Chemicals, Silanes, and Contract Manufacturing. It operates in India and internationally, with the majority of its revenue coming from India. In addition to the sale of products, the company also generates revenue from the sale of services.
78GF Score
Get the complete analysis for NSE:CHEMCON
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CHEMCON has been successfully added to your 
